School of Medicine


Showing 11-20 of 75 Results

  • Michael Scahill

    Michael Scahill

    Clinical Instructor, Pediatrics - Neonatal and Developmental Medicine

    Bio On a trip to Mozambique while in med school here at Stanford, I saw the power of market interventions to improve population health. In Pediatric Leadership for the Underserved residency at UCSF, I helped Jacaranda Health establish their pediatric clinic in Nairobi. Now, I split my time between the Stanford NICU and Virta, where I direct the digitally delivered diabetes reversal clinic.

  • David Scheinker

    David Scheinker

    Clinical Associate Professor, Pediatrics - Endocrinology and Diabetes

    Bio David Scheinker is the Director of Systems Design and Collaborative Research at the Stanford Lucile Packard Children's Hospital. He is the Founder and Director of SURF Stanford Medicine, a group that brings together students and faculty from the university with physicians, nurses, and administrators from the hospitals to improve the quality of care using operations research methodology. He received a PhD in theoretical math from The University of California San Diego under Jim Agler. Before coming to Stanford, he was a Joint Research Fellow at The MIT Sloan School of Management and Massachusetts General Hospital. His current areas of research include applications of operations research in healthcare, healthcare policy, mathematical control theory, and functional analysis.

    Concurrently with his university appointments, David has spent time teaching theoretical math to gifted 11 and 12 year old students for the Johns Hopkins Center for Talented Youth. He is writing a popular math book titled Infinity in Wonderland with the intent to bring the material of these courses to a wider audience.

  • Alan Schroeder

    Alan Schroeder

    Clinical Professor, Pediatrics

    Bio Dr. Schroeder is the associate chief for research in the division of pediatric hospital medicine at Lucile Packard Children?s Hospital Stanford, and a clinical professor in the division of hospital medicine and the division of critical care. His research interests focus on identifying areas where we can ?safely do less? in healthcare, and frequently lectures on this theme locally and nationally. Dr. Schroeder is currently involved in multiple projects involving common conditions and interventions in pediatrics such as head trauma, bronchiolitis, UTI, meningitis, febrile infant management, and third molar extractions. He is a co-chair of the Lown RightCare Alliance Pediatric Council, co-chair of the Academic Pediatric Association?s Healthcare Value Special Interest Group, an editor of the Yearbook of Pediatrics and an associate editor for the journal Hospital Pediatrics. Dr. Schroeder provides clinical care for children in the PICU and the pediatric ward.

  • Liora Schultz

    Liora Schultz

    Clinical Assistant Professor, Pediatrics - Hematology & Oncology

    Bio I am currently postdoctoral research fellow pursuing immunotherapy research in the oncology department at Stanford University. My clinical training as a pediatric hematology oncology fellow at Memorial Sloan Kettering Cancer Center highlighted the desperate need for novel therapeutic options for a subtype of aggressive pediatric leukemia, Acute Myeloid Leukemia (AML). Despite our best standard of care for AML, long term survival rates range from 50-60% with an unacceptably high relapse rate of 40%. The urgent need for novel treatments inspired me to pursue a research project in adoptive immunotherapy, genetically modifying Tcells to express artificial T cell receptors, termed chimeric antigen receptors (CARs), that target AML specific antigens. In parallel to my clinical training, I constructed an AML specific CAR and demonstrated its ability to redirect T cell function mediating eradication of AML cells. As the field of CAR therapy rapidly advances, novel methods to optimize this therapeutic modality are imperative. To this end, supported by research demonstrating superior antitumor function of naļve derived effector T cells compared to central memory derived effector T cells, I am investigating whether preferential modification of naļve T cells to express CARs will generate a T cell subpopulation with increased efficacy. Consolidating my clinical and research experiences within highly academic institutes allows me to synthesize my pursuit of scientific rigor and commitment to the field of oncology, with a mission to achieve productive research and translatable results.

  • Christopher Thomas Scott, PhD

    Christopher Thomas Scott, PhD

    Sr Research Scholar, Pediatrics - Center for Biomedical Ethics

    Current Research and Scholarly Interests My research focuses on the political, legal, ethical and economic impacts of stem cell research. Topics include: embryonic and adult stem cell research and clinical trials, stem cell banking, human-animal chimeras; cell and gamete donation; international perspectives of bioethics; global economic impacts; national and state regulatory policy, stem cell entrepreneurship, intellectual property and offshore stem cell transplants.

Footer Links:

Stanford Medicine Resources: